Not Yet Recruiting
Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer
NCT07117877
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China